Breaking News

BioNTech to Build mRNA Vaccine Mfg. Facility in Africa

The first mRNA manufacturing facility in Africa will enable an annual manufacturing capacity of several hundreds of million mRNA vaccine doses.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BioNTech SE plans to initiate the construction of the first state-of-the-art manufacturing site for mRNA-based vaccines in the African Union in mid-2022 to implement sustainable end-to-end vaccine supply solutions on the African continent. The decision follows a meeting between Rwanda’s Minister of Health, Dr. Daniel M. Ngamije, Senegal’s Minister of Foreign Affairs Aïssata Tall Sall, Ugur Sahin, M.D.,CEO and Co-Founder of BioNTech and Sierk Poetting, COO of BioNTech as well as Dr. Sabin Nsanzim...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters